A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma
Journal of Korean Medical Science
;
: 1-6, 1991.
Article
Dans Anglais
| WPRIM
| ID: wpr-169613
ABSTRACT
The authors conducted an investigation focusing mainly on the activities of the inhibitory factors of the coagulation and fibrinolysis processes in 35 normal adults and 72 liver cirrhosis and/or hepatoma patients. The activities of antithrombin III, protein C, and alpha 2-plasmin inhibitor were reduced to less than 50% in patients with decreased hepatic synthetic function while lupus anticoagulant was detected in more than 50% of patients with decreased hepatic synthetic function. Hemostatic abnormalities in advanced lived diseases may be caused partly by a decrease of coagulation and fibrinolysis inhibitors and the presence of lupus anticoagulant.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Facteurs de la coagulation sanguine
/
Inhibiteur lupique de la coagulation
/
Carcinome hépatocellulaire
/
Hémostase
/
Cirrhose du foie
/
Tumeurs du foie
/
Antifibrinolytiques
Limites du sujet:
Adulte
/
Humains
langue:
Anglais
Texte intégral:
Journal of Korean Medical Science
Année:
1991
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS